Endometriosis: Evolving Management Approaches

Endometriosis is a chronic, estrogen -dependent inflammatory disorder that affects nearly 10% of individuals of reproductive age worldwide. It is associated with severe pelvic pain, infertility, and profound psychosocial burden. Despite the absence of a def initive cure, recent evidence underscores the importance of prevention, early intervention, and comprehensive management. Strategies such as lifestyle modification, dietary interventions, hormonal suppression, and early diagnostic practices have shown pote ntial in reducing disease incidence, severity, and recurrence. This review integrates current insights into pathophysiology, preventive measures, systemic effects, infertility, and therapeutic approaches, highlighting the need for a holistic, multidiscipli nary framework spanning primary, secondary, and tertiary prevention.

Endometriosis; Pathophysiology; Prevention; Infertility; Mental health; Multidisciplinary management; Precision medicine; Recurrence. Copyright © 2025 The Author(s): This is an open -access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY-NC 4.0) which permits unrestricted use, distribution, and reproduction in any medium for non -commercial use provided the original author and source are credited.

Endometriosis is defined by the presence of endometrial-like tissue outside the uterine cavity, triggering inflammation, adhesions, and chronic pain, often culminating in infertility. Beyond reproductive health, it exerts systemic impacts, including gastrointestinal dysfunction, mood disorders, and elevated cardiovascular risks. Since curative therapies remain elusive, preventive and multidisciplinary strategies are increasingly emphasized to mitigate disease progression and improve quality of life. Etiologic Insights and Risk Factors Multiple genetic, hormonal, and environmental influences contribute to disease onset. • Reproductive and hormonal factors: Early menarche, short cycles, nulliparity, and low BMI increase susceptibility. • Genetic predisposition: Family history elevates risk by six- to nine-fold. • Congenital anomalies: Reproductive tract malformations predispose to retrograde flow. • Environmental influences: Endocrine-disrupting chemicals are emerging as potential contributors, though causality remains under investigation. Pathophysiology Endometriosis arises from interconnected biological processes: • Retrograde menstruation vs. stem cell theory: Sampson’s classic model explains peritoneal lesions, whereas stem cell theory accounts for extrapelvic disease via progenitor cells. • Immune dysfunction: Aberrant macrophages, cytokine overexpression (IL -1β, TNF -α), and impaired NK-cell activity facilitate lesion survival. • Hormonal imbalance: Estrogen dominance and progesterone resistance perpetuate inflammation and cellular proliferation. • Genetics and epigenetics: GWAS highlight loci such as WNT4, GREB1, and VEZT; epigenetic dysregulation (DNA methylation, miRNA alterations) modifies immune and endocrine pathways. • Gut microbiome: Dysbiosis alters estrogen metabolism and systemic inflammation, providing a novel pathogenic perspective. Preventive Strategies Primary Prevention – Delaying Onset and Reducing Risk • Lifestyle modification: Regular physical activity and smoking cessation reduce risk. • Dietary measures: o Omega-3 fatty acids lower risk by ~22%. Sannamma H J, Saudi J Nurs Health Care, Sep, 2025; 8(9): 241-243 © 2025 | Published by Scholars Middle East Publishers, Dubai, United Arab Emirates 242 o Diets rich in antioxidants (vitamins C, D, E) may alleviate symptoms. o High intake of red/processed meat increases risk, whereas dairy intake appears protective. • Hormonal modulation: Continuous hormonal contraceptives suppress retrograde menstruation. • Reproductive factors: Pregnancy and lactation confer temporary protective effects. Secondary Prevention – Early Detection and Control • Awareness and education: Early recognition of severe dysmenorrhea, especially in adolescents and those with family history. • Imaging advances: Transvaginal ultrasound and MRI are recommended as first-line diagnostic tools. • Biomarkers: Circulating miRNAs and liquid biopsies are under development for early disease detection. Tertiary Prevention – Reducing Recurrence and Optimizing Quality of Life • Post-surgical suppression: Prolonged hormonal therapy reduces recurrence rates. • Fertility preservation: Oocyte and ovarian tissue cryopreservation are vital for women at high risk. • Self-care strategies: A low-FODMAP diet relieves gastrointestinal symptoms in many patients. • Psychological support: Cognitive-behavioral therapy (CBT) and mindfulness improve coping and quality of life. Endometriosis and Infertility Infertility affects 30 –50% of affected women. Mechanisms include pelvic adhesions, defective folliculogenesis, impaired implantation, and altered endometrial receptivity. • Impact on ART outcomes: Severe disease reduces oocyte yield and pregnancy rates. • Recent advances: o Personalized ovarian stimulation minimizes iatrogenic damage. o AI-driven embryo selection improves implantation prediction. o Fertility preservation before repeat surgeries is increasingly advocated. Mental Health Considerations The chronic pain and reproductive challenges of endometriosis heighten vulnerability to depression, anxiety, OCD, and even suicidality. • Biological mechanisms: Pain-induced HPA axis disruption leads to neurotransmitter imbalance. • Emerging evidence (2024 –25): Pre-pregnancy endometriosis correlates with increased postpartum psychiatric disorders. • Clinical implications: Routine integration of mental health screening and interventions is essential within gynecological practice. Endometriosis as a Systemic Condition Endometriosis extends beyond gynecology, influencing multiple organ systems: • Cardiovascular: Increased risk of hypertension, stroke, and atherosclerosis. • Autoimmune: Strong associations with thyroid disease, lupus, and rheumatoid arthritis. • Gastrointestinal: IBS-like symptoms are frequent. • Musculoskeletal: Fatigue syndromes and fibromyalgia often overlap. Current and Emerging Management Approaches Medical Therapy • Hormonal therapy: Combined oral contraceptives, progestins, GnRH antagonists. • Pain control: NSAIDs and multimodal regimens. Surgical Options • Laparoscopic or robotic -assisted excision for symptom relief and fertility improvement. • High recurrence rates remain a challenge. Emerging Therapies • Immunomodulators and biologics: Anti-TNF and IL-6 inhibitors. • Non-hormonal agents: Angiogenesis inhibitors and epigenetic modulators. • Precision models: Patient-derived organoids for individualized drug testing. Psychological and Nursing Interventions • Counseling, CBT, mindfulness -based stress reduction, and peer support groups. • Nurses play pivotal roles in education, adherence support, and lifestyle guidance. Future Perspectives The future of endometriosis care lies in: • Genomic and biomarker-driven precision medicine. • Non-invasive diagnostics (AI -assisted imaging, liquid biopsy). • Integration of reproductive and mental health services. • Multidisciplinary care models uniting gynecology, psychiatry, endocrinology, and nursing. • A strong emphasis on prevention to reduce global disease burden.

Endometriosis is increasingly recognized as a complex systemic condition rather than a localized pelvic disease. Effective management demands preventive, holistic, and multidisciplinary strategies. Lifestyle and dietary interventions, early detection, and recurrence prevention—combined with precision medicine and mental health integration—offer the most promising path forward in reducing morbidity, infertility, and psychosocial distress associated with the disease. Sannamma H J, Saudi J Nurs Health Care, Sep, 2025; 8(9): 241-243 © 2025 | Published by Scholars Middle East Publishers, Dubai, United Arab Emirates 243

• Zondervan KT, Becker CM, Missmer SA. Endometriosis. N Engl J Med. 2020;382(13):1244– 1256. • Chapron C, Marcellin L, Borghese B, Santulli P. Rethinking mechanisms, diagnosis and management of endometriosis. Nat Rev Endocrinol. 2019;15(11):666–682. • Bulun SE, Yilmaz BD, Sison C, et al. , Endometriosis. Endocr Rev. 2019;40(4):1048–1079. • Vannuccini S, Clemenza S, Rossi M, et al., Infertility and endometriosis: new insights into pathogenesis and treatment. Reprod Biomed Online. 2022;44(4):589–601. • Smolarz B, Szyłło K, Romanowicz H. Endometriosis: epidemiology, classification, pathogenesis, treatment and genetics. Int J Mol Sci. 2021;22(19):10554. • Zondervan KT, Becker CM. Endometriosis and mental health: novel insights. Lancet Psychiatry. 2024;11(1):14–26. • Shigesi N, Kvaskoff M, Kirtley S, et al., The association between endometriosis and autoimmune diseases: a systematic review and meta -analysis. Hum Reprod Update. 2019;25(4):486–503. • Evans MB, Decherney AH. Fertility and endometriosis. Clin Obstet Gynecol. 2021;64(1):52– 63. • Leone Roberti Maggiore U, Ferrero S, Mangili G, et al., Endometriosis: pathogenesis, diagnosis, therapy and association with cancer. Obstet Gynecol Surv. 2016;71(7):413–432. • Guo SW. Recurrence of endometriosis and its control. Hum Reprod Update. 2009;15(4):441–461.